Canopy Growth Corp

Canopy Growth Corp has a debt-to-equity ratio of 0.67 and a current ratio of 3.12, indicating moderate leverage and strong short-term liquidity. However, the company's cash and equivalents amount to only CAD 130,000, which is significantly lower than its long-term debt of CAD 325,267,000, suggesting a liquidity risk. The company's profitability metrics are weak, with a return on equity of -1.2276 and a return on assets of -0.6518, both well below the industry median for pharmaceutical companies. These figures indicate that the company is not generating returns for shareholders or effectively utilizing its assets. Canopy Growth Corp's revenue is concentrated in a single business segment, cannabis cultivation and sales, with no disclosed geographic diversification. This concentration increases exposure to regulatory and market risks in the cannabis industry. The company's growth trajectory is uncertain, with no disclosed revenue growth in the most recent fiscal year. Analysts have provided a mean price target of CAD 2.36 and a median price target of CAD 1.80, with a mean recommendation of 2.83, indicating a mixed outlook. The company's risk assessment highlights a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt underscores the company's financial vulnerability. Recent events include a continued focus on cost reduction and operational efficiency, as disclosed in the company's latest financial filings. No major new product launches or strategic acquisitions were reported in the most recent quarter.